Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5832504 | International Immunopharmacology | 2015 | 9 Pages |
Abstract
Based on all the data obtained in different research studies, new potential therapeutic approaches have been proposed, including the use of new oral anticoagulants, statins, hydroxychloroquine, coenzyme Q10, B-cell depletion, platelet and TF inhibitors, peptide therapy or complement inhibition among others. Current best practice in use of these treatments is discussed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ch. Lopez-Pedrera, M.A. Aguirre, P. Ruiz-Limon, C. Pérez-Sánchez, Y. Jimenez-Gomez, N. Barbarroja, M.J. Cuadrado,